Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › CROWLEY › ACADIA GENERAL HOSPITAL, INC.

ACADIA GENERAL HOSPITAL, INC.

NPI: 1669882940 · CROWLEY, LA 70526 · General Acute Care Hospital · NPI assigned 05/07/2014

$8.42M
Total Medicaid Paid
332,549
Total Claims
280,311
Beneficiaries
151
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCALLECOD, DAVID (PRESIDENT, CEO)
Parent OrganizationLAFAYETTE GENERAL HEALTH SYSTEM, INC.
NPI Enumeration Date05/07/2014

Related Entities

Other providers sharing the same authorized official: CALLECOD, DAVID

ProviderCityStateTotal Paid
UNIVERSITY HOSPITAL & CLINICS, INC. LAFAYETTE LA $60.90M
ST MARTIN HOSPITAL, INC. BREAUX BRIDGE LA $12.79M
KAPLAN GENERAL HOSPITAL, INC. KAPLAN LA $3.98M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 50,507 $1.46M
2019 47,956 $1.32M
2020 44,229 $870K
2021 58,294 $1.15M
2022 47,696 $1.27M
2023 49,636 $1.35M
2024 34,231 $984K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 21,917 20,384 $2.17M
99283 Emergency department visit for the evaluation and management, moderate severity 23,750 22,419 $1.90M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 9,764 8,898 $1.12M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,457 5,891 $293K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 9,418 8,066 $236K
80053 Comprehensive metabolic panel 30,678 26,692 $208K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 27,158 23,761 $128K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,992 1,928 $121K
97597 6,552 3,296 $120K
96361 Intravenous infusion, hydration; each additional hour 3,002 2,263 $115K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5,124 4,214 $98K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 812 735 $89K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,116 1,069 $85K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 9,512 8,660 $83K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,625 2,245 $79K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,399 2,052 $79K
70450 Computed tomography, head or brain; without contrast material 757 676 $76K
71045 Radiologic examination, chest; single view 4,703 4,292 $70K
36415 Collection of venous blood by venipuncture 33,195 28,371 $65K
71046 Radiologic examination, chest; 2 views 3,138 2,804 $65K
0240U 667 575 $63K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 554 533 $62K
96375 Therapeutic injection; each additional sequential IV push 2,446 1,593 $62K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,040 857 $59K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,216 1,368 $59K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 509 476 $57K
J3490 Unclassified drugs 16,801 7,244 $51K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,206 644 $50K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,314 2,168 $50K
81025 7,197 6,727 $49K
80050 General health panel 1,005 969 $41K
80061 Lipid panel 3,130 2,970 $37K
84443 Thyroid stimulating hormone (TSH) 2,639 2,418 $35K
83880 1,809 1,643 $31K
84484 5,063 4,305 $31K
74176 Computed tomography, abdomen and pelvis; without contrast material 124 116 $29K
81001 13,677 12,063 $25K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 581 452 $24K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,350 4,963 $22K
74019 725 675 $19K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 287 240 $16K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 737 507 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 404 391 $15K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 404 391 $15K
87088 2,437 2,253 $15K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 59 47 $14K
74177 Computed tomography, abdomen and pelvis; with contrast material 59 53 $14K
85027 2,264 2,125 $14K
85730 4,372 3,837 $12K
77067 Screening mammography, bilateral, including computer-aided detection 221 207 $12K
83690 2,405 2,206 $11K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 303 292 $11K
85610 4,935 4,379 $10K
87631 189 184 $10K
J2469 Injection, palonosetron hcl, 25 mcg 261 127 $10K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 798 441 $9K
83036 Hemoglobin; glycosylated (A1C) 1,120 1,044 $9K
82553 1,438 1,296 $9K
J7030 Infusion, normal saline solution , 1000 cc 1,372 1,255 $7K
83735 1,966 1,580 $7K
99215 Prolong outpt/office vis 145 108 $7K
82550 1,906 1,715 $7K
84439 833 786 $7K
87449 511 474 $6K
87400 982 486 $6K
81003 4,299 3,719 $5K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 109 91 $5K
83605 755 607 $5K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 1,640 966 $4K
82077 417 371 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 173 157 $3K
96367 255 149 $3K
82150 632 572 $3K
87081 448 412 $3K
G0378 Hospital observation service, per hour 37 14 $3K
J8499 Prescription drug, oral, non chemotherapeutic, nos 1,499 1,009 $3K
80320 764 489 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg 369 351 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg 912 455 $2K
J7120 Ringers lactate infusion, up to 1000 cc 2,054 1,696 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor 61 60 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 111 91 $2K
96417 53 28 $2K
77063 Screening digital breast tomosynthesis, bilateral 72 66 $2K
80143 196 160 $2K
80048 Basic metabolic panel (calcium, ionized) 346 313 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 85 79 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 896 627 $2K
84100 531 388 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg 972 784 $1K
80179 117 106 $1K
85651 296 276 $1K
82728 120 106 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 12 12 $1K
87581 32 29 $982.52
J2704 Injection, propofol, 10 mg 3,100 2,539 $979.52
76700 Ultrasound, abdominal, real time with image documentation; complete 13 12 $893.60
72100 39 37 $851.40
83615 131 124 $830.86
85007 404 363 $791.52
74240 15 15 $741.40
82785 41 40 $736.00
J1453 Injection, fosaprepitant, 1 mg 41 25 $694.96
86803 57 51 $627.88
84550 130 124 $617.76
J2360 Injection, orphenadrine citrate, up to 60 mg 30 27 $537.51
80074 13 13 $523.93
17250 45 28 $508.32
87040 119 62 $507.01
82607 45 42 $497.36
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 15 13 $463.75
A9150 Non-prescription drugs 247 212 $433.77
J3010 Injection, fentanyl citrate, 0.1 mg 1,490 1,265 $393.65
83540 93 79 $354.92
83550 64 54 $349.60
87077 63 49 $312.09
80329 147 68 $294.67
87070 77 65 $250.16
J0690 Injection, cefazolin sodium, 500 mg 882 617 $248.21
J7050 Infusion, normal saline solution, 250 cc 28 24 $211.73
90715 12 12 $196.40
72070 12 12 $189.80
84436 33 33 $181.66
84479 33 33 $176.39
87075 45 41 $174.07
94761 28 13 $164.32
86140 26 25 $126.43
74248 15 15 $126.28
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 15 14 $119.68
87184 31 25 $115.35
84481 12 12 $114.84
80069 12 12 $95.48
J0780 Injection, prochlorperazine, up to 10 mg 13 12 $94.74
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study 41 39 $89.36
87086 Culture, bacterial; quantitative colony count, urine 14 14 $88.77
82962 14 14 $74.98
J1170 Injection, hydromorphone, up to 4 mg 191 91 $73.74
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 961 727 $62.01
82570 13 12 $56.98
82270 14 14 $38.76
84156 12 12 $36.70
87205 12 12 $21.35
J2250 Injection, midazolam hydrochloride, per 1 mg 76 67 $16.34
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 120 100 $16.03
J2003 Injection, lidocaine hydrochloride, 1 mg 54 45 $13.61
J1171 Injection, hydromorphone, 0.1 mg 22 12 $0.00
02414 12 12 $0.00
02404 15 12 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1,373 721 $0.00
A9270 Non-covered item or service 183 106 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 13 12 $0.00